References
Grubb BP. Neurocardiogenic syncope. In: Grubb BP, Olshansky B, eds. Syncope: Mechanisms and Management. Armonk, NY: Futura Publishing, 1998;73-106.
Lewis T. Vasovagal syncope and the carotid sinus mechanism with comments on Gower's and Nothnagel's syndrome. Br Med J 1932;1:873-876.
Kenny RA, Ingram A, Bayliss J, Sutton R. Head up tilt: A useful test for investigating unexplained syncope. Lancet 1986;2:1352-1354.
Fitzpatrick A, Sutton R. Tilting toward a diagnosis in unexplained recurrent syncope. Lancet 1989;1:658-660.
Fitzpatrick A, Williams T, Ahmed R, et al. Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head up tilt. Eur J Cardiac Pacing Electrophysiol 1992;2:121-128.
Grubb BP, Gerard G, Roush K, et al. Cerebral vasoconstriction during head upright tilt-induced vasovagal syncope. Circulation 1991;84:1157-1164.
Rea R, Thames M. Neural control mechanisms and vasovagal syncope. J Cardiovasc Electrophysiol 1993;4:587-595.
Saxena PR. Historical aspects of 5-hydroxytryptamine, discovery and receptor classification. In: Olesen J, Saxena PR, eds. 5-hydroxytryptamine Mechanisms in Primary Headaches. New York: Raven Press, 1992;3-18.
Erspamer V. Pharmacology of indolealkylamines. Pharmacol Rev 1954;6:425-487.
Rapport MM, Green AA, Page IH. Serum vasoconstrictor (serotonin): Isolation and characterization. J Biol Chem 1948;176:1243-1251.
Bard P. Anatomical organization of the central nervous system in relation to control of the heart and blood vessels. Physiol Rev 1960;4:3-53.
Dahlström A, Fuxe K. Evidence for the existence of monomine neurons in the central nervous system. Acta Physiol Scand 1965;64:1-7.
Jacobs B, Azmitia E. Structure and function of the brain serotonin system. Physiol Rev 1992;72:165-229.
Benarroch E. The central autonomic network: Functional organization, dysfunction, and perspective. Mayo Clin Proc 1993;68:988-1001.
Fuller RW. Neural functions of serotonin. Scientific American Sci Med 1995;4:48-57.
Fuller RW. New developments in serotonin pharmacology. In: Ruffo R, Hollinger M, eds. G Protein Coupled Trans-Membrane Signaling Mechanisms. Boca Raton, Florida: CRC Press, 1995.
Boadle-Biber MC. Regulation of serotonin synthesis. Prog Biophys Molec Biol 1993;60:1-15.
Silberstein SD. Serotonin (5-HT) and migraine headache. Headache 1994;34:408-417.
Gonzales-Heydrich J, Peroutka S. Serotonin receptor and reuptake sites: Pharmacologic significance. J Clin Psychiatry 1990;51:5-12.
Hoyer D. International union of pharmacology classifications of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203.
Kuhn D, Wolfe W, Loyenburg W. Review of the role of the central serotonergic neuronal system in blood pressure regulation. Hypertension 1980;2:243-255.
Baum T, Shropshire AT. Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan in centrally administered 5-hydroxytryptamine. Neuropharmacology 1975;14: 227-233.
Tadepelli A, Mills E, Schanberg S. Central depressor of carotid baroreceptor pressor response, arterial pressure and heart rate by 5-hydroxytryptophan: Influence of the supra-molecular areas of the brain. J Pharmacol Exper Therap 1977;202:310-319.
Strasberg B, Jagie A, Erdmann S et al. Carotid sinus hypersensitivity and the carotid sinus syndrome. Prog Cardiovasc Dis 1989;5:379-385.
Antonaccio MJ, Robson RD. Centrally-mediated cardiovascular effects of 5-hydroxytryptophan in MAO-inhibited dogs: Modification by autonomic antagonists. Arch Intern Pharmacodynamics 1975;213:200-210.
Chosy JJ, Graham DT. Catecholamines in vasovagal fainting. J Psychosomatic Res 1965;9:189-194.
Sra J. Jazayeri M. Murthy V et al. Sequential catecholamine changes during upright tilt: Possible hormonal mechanisms responsible for pathogenesis of neurocardiogenic syncope. J Am Coll Cardiol 1991;17:216A (Abstract).
Lewis W, Smith M, Carlson M. Peripheral sympathoinhibition precedes hypotension and bradycardia during neurally-mediated vasovagal syncope. PACE 1994;17:747. (Abstract).
Skoog P, Mansson J. Theen P. Changes in renal sympathetic outflow during hypotensive hemorrhage in rats. Acta Physiol Scand 1985;125:655-660.
Schadt JC, Ludbrook J. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol (Heart Circ Physiol 29) 1991;260:H305-H308.
Morgan DA, Thoren P, Wilczynski E et al. Serotonergic mechanisms mediate renal sympatho-inhibition during severe hemorrhage in rats.AmJ Physiol 1988;255:H496–H502.
Elam RF, Bergman F, Feverstein G. The use of antiserotonergic agents for the treatment of acute hemorrhagic shock in cats. Eur J Pharmacol 1985;107:275-278.
Hasser E, Schadt J, Grove K. Serotonergic and apioid interactions during acute hemorrhagic hypotension in the conscious rabbit. FASEB J 1989;3:A1014. (Abstract).
Evans RG, Kapoor V, Ludbrook J. A CNS serotonergic mechanism in acute central hypovolemia in conscious rabbits? J Cardiovasc Pharmacol 1992;19(6):1009-1017.
Abboud FM. Neurocardiogenic syncope. N Engl J Med 1993;328:1117-1119.
Matzen S, Secher NH, Knigge U, et al. Effect of serotonin receptor blockade on endocrine and cardiovascular responses to head up tilt in humans. Acta Physiol Scand 1993;149:163-176.
Theodorakis G, Markianos M, Sourlas N, et al. Central serotonergic and beta adrenergic activity in patients with vasovagal syncope. Circulation 1995;92:414.
Theodorakis G, Flevari P, Livanis E, et al. Clomipramine challenge during tilt test and central serotonergic activity. Circulation 1997;96:221.
Lehnert H, Lombardi F, Raeder E, et al. Increased release of brain serotonin reduces vulnerability of ventricular fibrillation in the cat. J Cardiovasc Pharmacol 1987;10:389-397.
Verrier R. Neurochemical approaches to the prevention of ventricular fibrillation. Federation Proc 1986;45:2191-2196.
Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976;294:1165-1170.
Rabinowitz SH, Lown B. Central neurochemical factors related to serotonin metabolism and cardiac vulnerability for repetitive electrical activity. Am J Cardiol 1978;41:516-522.
Blatt CM, Rabinowitz SH, Lown B. Central serotonergic agents raise the repetitive extrasystole threshold of the vulnerable period of the canine ventricular myocardium. Circ Res 1979;44:723-730.
Rickels K, Schweizer E. Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 1990;51:9-12.
Fuller RW, Wong DT. Serotonin reuptake blockers in vitro and in vivo. J Clin Psychopharmacol 1987;7:445-495.
Delgado P. Serotonin and the neurobiology of major depression. Psychopharmacol Bull 1991;27:321-330.
Preskorn SH. Pharmacokinetics of antidepressants. J Clin Psychiatry 1993;54:14-34.
Fontaine R, Ontiveros A, Elie R et al. A double blind trial of nefazodone, imipramine and placebo in major depression. J Clin Psychiatry 1994,55:234-241.
Hjorth S, Sharp T. In vivo microdialysis evidence for central serotonin 1A and 1B autoreceptor of the beta receptor antagonist penbutolol. J Pharmacol Exp Therap 1993:265:707-712.
Hjorth S. Penbutolol as a blocker of central 5-HY1A receptor mediated responses. Eur J Pharmacol 1992;222:121-127.
Meltzer HY, Maes M. Effect of pindolol on the L-5HTP-induced increase in plasma and cortisol concentrations in man. Psychopharmacology 1994;114:635-643.
Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitos. Arch Gen Psychiatry 1994;51:148-251.
Kosinski D, Grubb BP, Temesy-Armos P. Pathophysiological aspects of neurocardiogenic syncope. PACE 1995;18:716-724.
Sutton R, Petersen M. The clinical spectrum of neurocardiogenic syncope. J Cardiovasc Eletrophysiol 1995;6:569-576.
Grubb BP, Wolfe D, Samoil D, et al. Usefulness of fluoxetine hydrochloride for prevention of upright tilt-induced syncope. PACE 1992;15:742-748.
Grubb BP, Samoil D, Kosinski D, et al. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994;24:490-492.
Dan D, Grubb BP, Mouhaffel A, et al. Preliminary observations on the use of nefazodone, a new selective 5-HT2A receptor blocker in the treatment of neurally mediated syncope. Eur J Card Pace Electrophysiol 1996;6:89-94.
Williamson BD, Strickberger A, Ching Man K, et al. A randomized trial of sertraline versus atenolol and disopyramide in the treatment of neurocardiogenic syncope. PACE 1994; 17:747. (Abstract).
Constantin L, Martins JB, Fincham RW, et al. Bradycardia and syncope as manifestations of partial epilepsy. J Am Coll Cardiol 1990;15:900-905.
Löfring V. Cardiovascular adjustments induced from the rostral cingulate gyrus, with specific reference to sympathoinhibiting mechanisms. Acta Physiol Scand 1961;54(Suppl 184):55-82.
Crippen D. Stress, agitation and brain failure in critical care medicine. Crit Care Q 1992;15:52-74.
Crippen D. Understanding the neurohumoral causes of anxiety in the ICU. J Crit Illness 1995;10(8):550-560.
Kenny RA, Traynor G. Carotid sinus syndrome—clinical characteristics in elderly patients. Age and Aging 1991;20: 449-454.
Almquist A, Gormick C, Benson W, et al. Carotid sinus hypersensitivity: Evaluation of the vasodepressor component. Circulation 1985;71:5:927-936.
Zee-Cheng CS, Gibbs HR. Pure vasodepressor carotid sinus hypersensitivity.Am J Med 1986;1095-1097.
Grubb BP, Samoil D, Kosinski D, et al. The use of serotonin reuptake inhibitors for the treatment of recurrent syncope due to carotid sinus hypersensitivity unresponsive to dual chamber cardiac pacing. PACE 1994;17:1434-1436.
Dan D, Grubb BP, Mouhaffel A, Kosinski D. Use of serotonin reuptake inhibitors as a primary therapy for carotid sinus hypersensitivity. PACE 1997;20:1633-1735.
Pilgrim J, Stansfeld S, Marmot M. Low pressure, low mood? Br Med J 1992;304:75-78.
Barrett-Conner E, Palinkas L. Low blood pressure and depression in older men: A population based study. Br Med J 1994;308:446-448.
Grubb BP. Dysautonomic syncope. In: Grubb BP, Olshansky B, eds. Syncope: Mechanisms and Management. Armonk, NY: Futura Publishing, 1998;107-126.
Grubb BP, Samoil D, Kosinski D, Wolfe DA. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am J Med 1994;97:366-368.
Grubb BP, Kosinski D. Preliminary observations on the effects of venlafaxine hydrochloride in the treatment of severe refractory orthostatic hypotension. J Serotonin Res 1996;3: 85-89.
Dheenan S, Venkatesan J, Grubb BP, Henrich W. Effect of sertraline hydrochloride on dialysis hypotension. Am J Kidney Dis 1998;31:624-630.
Grubb BP, Kosinski D. Serotonin and syncope: An emerging connection? Eur J Cardiac Pacing Electrophysiol 1996;5: 306-314.
Azmitia EC, Whitaker-Azmitia PM. Awakening the sleeping giant: Anatomy and plasticity of the brain serotonergic system. J Clin Psychiatry 1991;52:4-16.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grubb, B.P., Karas, B.J. The Potential Role of Serotonin in the Pathogenesis of Neurocardiogenic Syncope and Related Autonomic Disturbances. J Interv Card Electrophysiol 2, 325–332 (1998). https://doi.org/10.1023/A:1009792000490
Issue Date:
DOI: https://doi.org/10.1023/A:1009792000490